Cabozantinib in neuroendocrine tumors: tackling drug activity and resistance mechanisms.
Cella CA, Cazzoli R, Fazio N, De Petro G, Gaudenzi G, Carra S, Romanenghi M, Spada F, Grossi I, Pallavicini I, Minucci S, Vitale G.
Cella CA, et al. Among authors: de petro g.
Endocr Relat Cancer. 2023 Oct 18;30(12):e230232. doi: 10.1530/ERC-23-0232. Print 2023 Dec 1.
Endocr Relat Cancer. 2023.
PMID: 37855330
Free PMC article.